Home LiteratureArticle Details
PMID: 9295365 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin.

Capogna M, McKinney RA, O'Connor V, Gähwiler BH, Thompson SM

Abstract

Botulinum (BoNT/A-G) and tetanus toxins (TeNT) are zinc endopeptidases that cleave proteins associated with presynaptic terminals (SNAP-25, syntaxin, or VAMP/synaptobrevin) and block neurotransmitter release. Treatment of hippocampal slice cultures with BoNT/A, BoNT/C, BoNT/E, or TeNT prevented the occurrence of spontaneous or miniature EPSCs (sEPSCs or mEPSCs) as well as the [Ca2+]o-independent increase in their frequency induced by phorbol ester, 0.5 nM alpha-latrotoxin, or sucrose. [Ca2+]o-independent and -dependent release thus requires that the target proteins of clostridial neurotoxins be uncleaved. In contrast, significant increases in mEPSC frequency were produced in BoNT-treated, but not TeNT-treated, cultures by application of the Ca2+ ionophore ionomycin in the presence of 10 mM [Ca2+]o. The frequency of sEPSCs was increased in BoNT-treated, but not TeNT-treated, cultures by increasing [Ca2+]o from 2.8 to 5-10 mM or by applying 5 mM Sr2+. Large Ca2+ and Sr2+ influxes thus can rescue release after BoNT treatment, albeit less than in control cultures. The nature of the toxin-induced modification of Ca2+-dependent release was assessed by recordings from monosynaptically coupled CA3 cell pairs. The paired-pulse ratio of unitary EPSCs evoked by two presynaptic action potentials in close succession was 0.5 in control cultures, but it was 1.4 and 1.2 in BoNT/A- or BoNT/C-treated cultures when recorded in 10 mM [Ca2+]o. Log-log plots of unitary EPSC amplitude versus [Ca2+]o were shifted toward higher [Ca2+]o in BoNT/A- or BoNT/C-treated cultures, but their slope was unchanged and the maximal EPSC amplitudes were reduced. We conclude that BoNTs reduce the Ca2+ sensitivity of the exocytotic machinery and the number of quanta released.

MeSH Terms
Animals Botulinum Toxins/pharmacology Calcium/pharmacology Cells, Cultured Evoked Potentials/drug effects Excitatory Amino Acid Antagonists/pharmacology Hippocampus/cytology,drug effects,physiology In Vitro Techniques Membrane Proteins/drug effects,metabolism Neurotransmitter Agents/antagonists & inhibitors Rats SNARE Proteins Strontium/pharmacology Synaptic Transmission/drug effects Tetanus Toxin/pharmacology Vesicular Transport Proteins
Chemicals
Excitatory Amino Acid Antagonists Membrane Proteins Neurotransmitter Agents SNARE Proteins Tetanus Toxin Vesicular Transport Proteins Botulinum Toxins Calcium Strontium
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Capogna M
Brain Research Institute, University of Zurich, CH-8029 Zurich, Switzerland.
McKinney R A
O'Connor V
Gähwiler B H
Thompson S M
References (65)
65 references, click to expand
  1. Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature.
    Pflugers Arch. 1983 Nov;399(3):228-34 PMID: 6140670
  2. Clostridial neurotoxins: new tools for dissecting exocytosis.
    Trends Cell Biol. 1994 May;4(5):179-85 PMID: 14731646
  3. A post-docking role for synaptobrevin in synaptic vesicle fusion.
    Neuron. 1994 Jun;12(6):1269-79 PMID: 8011337
  4. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin.
    EMBO J. 1993 Dec;12(12):4821-8 PMID: 7901002
  5. Phosphorylation of 25-kDa synaptosome-associated protein. Possible involvement in protein kinase C-mediated regulation of neurotransmitter release.
    J Biol Chem. 1996 Jun 14;271(24):14548-53 PMID: 8662851
  6. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa.
    J Biol Chem. 1996 Mar 29;271(13):7694-9 PMID: 8631808
  7. Botulinum A and the light chain of tetanus toxins inhibit distinct stages of Mg.ATP-dependent catecholamine exocytosis from permeabilised chromaffin cells.
    Eur J Biochem. 1994 Jun 1;222(2):325-33 PMID: 8020471
  8. Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction.
    Acta Physiol Scand. 1989 Dec;137(4):497-501 PMID: 2557728
  9. Effects of botulinum toxin on neuromuscular transmission in the rat.
    J Physiol. 1976 Aug;260(1):177-203 PMID: 184273
  10. Syntaxin and synaptobrevin function downstream of vesicle docking in Drosophila.
    Neuron. 1995 Sep;15(3):663-73 PMID: 7546745
  11. Impairment of syntaxin by botulinum neurotoxin C1 or antibodies inhibits acetylcholine release but not Ca2+ channel activity.
    Neuroscience. 1995 Apr;65(3):905-15 PMID: 7609887
  12. Phorbol esters enhance transmitter release in rat hippocampal slices.
    Brain Res. 1987 Feb 10;403(1):198-203 PMID: 2881605
  13. Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions.
    J Physiol (Paris). 1990;84(2):152-66 PMID: 2290130
  14. Quantal neurotransmitter release and the clostridial neurotoxins' targets.
    Curr Top Microbiol Immunol. 1995;195:243-55 PMID: 8542756
  15. Spontaneous subthreshold activity at motor nerve endings.
    J Physiol. 1952 May;117(1):109-28 PMID: 14946732
  16. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.
    J Biol Chem. 1993 Nov 15;268(32):23784-7 PMID: 8226912
  17. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
    Eur J Biochem. 1996 Mar 15;236(3):877-86 PMID: 8665909
  18. Effects of black widow spider venom on the frog neuromuscular junction. Effects on end-plate potential, miniature end-plate potential and nerve terminal spike.
    Nature. 1970 Feb 21;225(5234):701-3 PMID: 4312878
  19. Calcium ionophore X-537A increases spontaneous and phasic quantal release of acetylcholine at frog neuromuscular junction.
    Nature. 1974 Aug 23;250(5468):658-60 PMID: 4546740
  20. Calcium-independent activation of the secretory apparatus by ruthenium red in hippocampal neurons: a new tool to assess modulation of presynaptic function.
    J Neurosci. 1996 Jan;16(1):46-54 PMID: 8613808
  21. From vesicle docking to endocytosis: intermediate reactions of exocytosis.
    Neuron. 1995 Apr;14(4):689-96 PMID: 7718232
  22. Increased transmitter release at excitatory synapses produced by direct activation of adenylate cyclase in rat hippocampal slices.
    J Neurosci. 1994 Jan;14(1):310-7 PMID: 7506766
  23. The effect of type D botulinum toxin on frog neuromuscular junctions.
    J Physiol. 1971 Sep;217(2):497-515 PMID: 4329008
  24. Organotypic monolayer cultures of nervous tissue.
    J Neurosci Methods. 1981 Dec;4(4):329-42 PMID: 7033675
  25. Direct modulation of the secretory machinery underlies PKA-dependent synaptic facilitation in hippocampal neurons.
    Neuron. 1996 Oct;17(4):789-97 PMID: 8893035
  26. Miniature excitatory synaptic currents in cultured hippocampal neurons.
    Brain Res. 1990 Jun 4;518(1-2):257-68 PMID: 1697209
  27. Is the internal calcium regulation altered in type A botulinum toxin-poisoned motor endings?
    Brain Res. 1989 Feb 6;479(1):167-71 PMID: 2538205
  28. Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion.
    EMBO J. 1995 Oct 2;14(19):4705-13 PMID: 7588600
  29. The synaptic vesicle cycle: a cascade of protein-protein interactions.
    Nature. 1995 Jun 22;375(6533):645-53 PMID: 7791897
  30. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
    Biochemistry. 1996 Feb 27;35(8):2630-6 PMID: 8611567
  31. Definition of the readily releasable pool of vesicles at hippocampal synapses.
    Neuron. 1996 Jun;16(6):1197-207 PMID: 8663996
  32. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion.
    Cell. 1993 Nov 5;75(3):409-18 PMID: 8221884
  33. Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins.
    Curr Top Microbiol Immunol. 1995;195:257-74 PMID: 8542757
  34. Exocytosis: a molecular and physiological perspective.
    Neuron. 1996 Dec;17(6):1049-55 PMID: 8982154
  35. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.
    Nature. 1992 Oct 29;359(6398):832-5 PMID: 1331807
  36. Distinct Ca2+ and Sr2+ binding properties of synaptotagmins. Definition of candidate Ca2+ sensors for the fast and slow components of neurotransmitter release.
    J Biol Chem. 1995 Oct 20;270(42):24898-902 PMID: 7559614
  37. Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin.
    J Neurophysiol. 1987 Jan;57(1):121-31 PMID: 3031230
  38. Two components of transmitter release at a central synapse.
    Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12942-6 PMID: 7809151
  39. Co-operative action a calcium ions in transmitter release at the neuromuscular junction.
    J Physiol. 1967 Nov;193(2):419-32 PMID: 6065887
  40. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Nature. 1993 Sep 9;365(6442):160-3 PMID: 8103915
  41. Genetic and electrophysiological studies of Drosophila syntaxin-1A demonstrate its role in nonneuronal secretion and neurotransmission.
    Cell. 1995 Jan 27;80(2):311-20 PMID: 7834751
  42. Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin.
    Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):1-7 PMID: 2883583
  43. Alpha-latrotoxin and related toxins.
    Pharmacol Ther. 1989;42(1):115-34 PMID: 2657806
  44. Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals.
    Pflugers Arch. 1987 Aug;409(4-5):533-9 PMID: 2888074
  45. Presynaptic enhancement of synaptic transmission in hippocampal cell cultures by phorbol esters.
    Brain Res. 1990 Jun 4;518(1-2):269-73 PMID: 2167749
  46. Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules.
    Neuron. 1996 Jun;16(6):1209-20 PMID: 8663997
  47. Common and distinct fusion proteins in axonal growth and transmitter release.
    J Comp Neurol. 1996 Apr 01;367(2):222-34 PMID: 8708006
  48. Cleavage of syntaxin prevents G-protein regulation of presynaptic calcium channels.
    Nature. 1997 Jan 23;385(6614):340-3 PMID: 9002518
  49. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects.
    Neuron. 1995 Feb;14(2):341-51 PMID: 7857643
  50. SNAP receptors implicated in vesicle targeting and fusion.
    Nature. 1993 Mar 25;362(6418):318-24 PMID: 8455717
  51. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release.
    J Physiol. 1996 Feb 15;491 ( Pt 1):163-76 PMID: 9011608
  52. VAMP/synaptobrevin isoforms 1 and 2 are widely and differentially expressed in nonneuronal tissues.
    J Cell Biol. 1996 Jan;132(1-2):167-79 PMID: 8567721
  53. Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis.
    Biochem Biophys Res Commun. 1992 Dec 15;189(2):1017-23 PMID: 1361727
  54. Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly.
    EMBO J. 1994 Nov 1;13(21):5051-61 PMID: 7957071
  55. Nitric oxide modulates synaptic vesicle docking fusion reactions.
    Neuron. 1996 Jun;16(6):1229-36 PMID: 8663999
  56. Phorbol esters enhance synaptic transmission by a presynaptic, calcium-dependent mechanism in rat hippocampus.
    J Physiol. 1993 Nov;471:245-68 PMID: 8120806
  57. SNAP-25 is required for a late postdocking step in Ca2+-dependent exocytosis.
    J Biol Chem. 1996 Aug 23;271(34):20227-30 PMID: 8702751
  58. Calcium-independent actions of alpha-latrotoxin on spontaneous and evoked synaptic transmission in the hippocampus.
    J Neurophysiol. 1996 Nov;76(5):3149-58 PMID: 8930262
  59. Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses.
    Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):997-1001 PMID: 9023371
  60. Botulinum A toxin and tetanus toxin do not affect presynaptic membrane currents in mammalian motor nerve endings.
    Brain Res. 1983 Jul 4;270(2):373-5 PMID: 6309330
  61. Presynaptic enhancement of inhibitory synaptic transmission by protein kinases A and C in the rat hippocampus in vitro.
    J Neurosci. 1995 Feb;15(2):1249-60 PMID: 7869096
  62. Quantal acetylcholine release at the vertebrate neuromuscular junction.
    Physiol Rev. 1994 Oct;74(4):899-991 PMID: 7938228
  63. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.
    J Biol Chem. 1994 Jan 21;269(3):1617-20 PMID: 8294407
  64. Expression and complex formation of soluble N-ethyl-maleimide-sensitive factor attachment protein (SNAP) receptors in clonal rat endocrine cells.
    Neurosci Lett. 1995 Feb 17;186(2-3):208-10 PMID: 7777198
  65. The role of calcium in neuromuscular facilitation.
    J Physiol. 1968 Mar;195(2):481-92 PMID: 4296699
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
0270-6474
Published
1997-10-01
Pages
7190-202
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6573450
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]